Business Wire

Total Safety Germany / Austria Becomes First Stand-Alone IPSC to Achieve ISO Certification in Europe

Del

Total Safety, Europe announced today that its Germany / Austria Division not only has its SCCP and ISO 9001 certification at the country level and now has also achieved this distinction uniquely at its BASF Ludwigshafen In-Plant Service Center (IPSC), the first major stand-alone certified IPSC in Europe.

The news came via official letter from the DNV GL Business Assurance Unit, the accredited certification body that handles the compliance of companies for third-party standards including ISO 9001 (quality management system) and ISO 14001 (environmental management system). DNV GL is the accredited certifier in 80 countries across all industry sectors.

Total Safety Germany-Austria, certified like every European Total Safety entity on a country level since the start of business activities in the 1990s, began working on SCCP and ISO certification for individual IPSCs in the fall of 2014 while under the leadership of Tony Zadnikar. He credits this achievement to the commitment and teamwork of every worker and the positive quality and safety focused cooperation with customers like BASF and many others.

“Business, no matter what the objective, is always about people,” said Zadnikar, who has since been promoted to Regional Manager - Europe. “Our teams create, ensure and set quality standards, while delivering safety solutions that help people be successful handling daily operational challenges in a safe way.

“Protecting the safe Wellbeing of Workers Worldwide is not only our mission, but it is also our way of life,” he added. “We embrace it with passion throughout our organization in a continuous search to further improve global service capabilities.”

The certificate was presented in late November by DNV GL Lead Auditor Frank Nicolaus in Marl, Germany to Total Safety’s Oliver Wörner, IPSC Lead BASF; Christian Hochberger, Coordinator BASF; and Jörg Teige, HSEQ Officer Germany / Austria.

Total Safety’s initiative in Germany and Austria is indicative of the company’s focus to lean in and maintain leadership in safety solutions and technology on behalf of clients and their workers throughout Europe and around the world.

“Our team in Germany and Austria has worked diligently to document and satisfy all requirements for these stringent SCCP and ISO standards. Their commitment to safety sets the bar for all IPSCs, not just in our company but throughout the industry,” said Chief Operating Officer Paul Tyree. “We know it is greatly appreciated by our valuable customers at BASF.”

Total Safety is committed to bringing the stringent SCCP and ISO Standards to the customer level to reinforce quality and safety standards, and certify processes on location where it counts. Certifying IPSCs sets a unique new standard in the industry for sub-contracted, embedded facilities and ensures customers that a higher standard of performance and risk management is in place.

“We will continue to certify standalone IPSCs in Europe over the coming months,” Zadnikar said. “Our next planned sites are SHELL Pernis, The Netherlands, TOTAL Antwerp Olefins, Belgium and BP Gelsenkirchen, Germany followed by other individual customer IPSC locations.”

The DNV GL documented the certification of Total Safety’s BASF Ludwigshafen IPSC for “adherence to ISO Standards in safety engineering and coordination of maintenance work, stoppages and projects; training and use of security personnel as well as sale, rental, maintenance, repair, operation and testing of work equipment and their warehouse management and logistics.”

“As the global leader in safety and compliance services, Total Safety employees have a profound sense of shared responsibility to adhere to the standards and regulatory requirements that have been put in place to protect people, the environment, and to reduce risk,” said President and Chief Executive Officer Troy Thacker. “So, there is also a shared sense of admiration and accomplishment for our employees in Germany and Austria on their tremendous achievement and the ongoing work of our teams throughout Europe to extend this standard to all IPSCs.”

About Total Safety

Total Safety®, a Warburg Pincus portfolio company, is the world’s premier provider of integrated safety and compliance services and the products necessary to support them, including gas detection, respiratory protection, safety training, fire protection, compliance and inspection, comprehensive flare services, industrial hygiene, onsite emergency medical treatment/paramedics, communications systems, engineered systems design, and materials management. It operates from 150 locations in 21 countries to ensure the safe Wellbeing of Workers Worldwide (W3). For more information about Total Safety and its unwavering commitment to safety, visit www.totalsafety.com.

Contact information

Total Safety
Cindy Lenssen, +32 (0)89 300 903
clenssen@totalsafety.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i